RoosterBio, MineBio team up to expand MSC solutions access in China

RoosterBio has entered an exclusive distributor partnership with MineBio Life Sciences to expand access to scalable, research-grade and current good manufacturing practice (cGMP)-grade mesenchymal stem cell (MSC) and exosome bioprocessing solutions across China.

MineBio will supply RoosterBio’s complete platform of products, having already obtained import clearance.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.


Find out more

This facilitates prompt fulfilment of orders for both research and clinical-grade media solutions focused on MSC and exosome development.

RoosterBio’s CliniControl product portfolio encompasses cGMP-manufactured MSC expansion media, exosome collection media, bioreactor feeds, and genetic engineering media.

These offerings are designed to support continuous product development, from early research to cGMP manufacturing.

They are supplied with extensive quality and regulatory documentation, including US Food and Drug Administration (FDA) Type II Master Files and dossiers for global trials.

RoosterBio’s platform has been used in GMP manufacturing since 2019, providing regulatory support and product uniformity for advanced therapy developers.

MineBio’s established position in the regenerative medicine, stem cell, and cell and gene therapy sectors enables it to support developers throughout China by delivering RoosterBio’s solutions.

RoosterBio CEO Tim Kelly said: “China has emerged as a global leader in MSC and exosome clinical research, with one of the highest concentrations of active trials anywhere in the world.

“We have long sought the right partner to bring our platform to this market, someone who is deeply embedded in the Chinese cell and gene therapy community and genuinely trusted by the developers working to bring these therapies to patients.

“MineBio’s expertise, robust customer network, and commitment to quality make them the ideal collaborator to expand access to RoosterBio’s RUO and cGMP media solutions. We are thrilled to work together to help China’s innovators increase their productivity and move faster from the bench to the clinic.”


Source link

Visited 1 times, 1 visit(s) today

Related Article

What Has Changed For indie Semiconductor Since Its 66% Fall

indie Semiconductor has been busy, from reporting Q1 2026 revenue of US$55.5 million and a new US$25 million radar order to agreeing a €40 million CMOS sensor deal with ams OSRAM and launching the iND881 edge AI chip. For indie Semiconductor shareholders, the loss over the past year was 65.8%, including dividends. If you had

3 Canadian Growth Stocks With At Least 43% Earnings Growth

Accelerating US inflation, driven by sharp moves in energy prices, keeps pressure on interest rates and has made dependable earnings growth harder to find. That is where a group of financially solid Canadian growth stocks becomes interesting. According to analyst estimates, these companies are projected to increase profits over the next few years while maintaining

Trump’s Marijuana Order Is Stuck at the DEA. Here’s What That Means for Canopy Growth.

Last December, President Donald Trump issued Executive Order 14370, intended to fast-track the rescheduling of marijuana to Schedule III, in turn paving the way for federal regulatory clarity. At the time, marijuana stocks, including Canopy Growth (NASDAQ: CGC), surged sharply on the news, with Canopy itself surging from $1.15 to nearly $2 per share. Shares

Tenaz Energy And 2 Canadian Founder Led Growth Stocks

Powered by spikes in energy prices, September inflation reached 3.7% in the latest US data and reminded investors how quickly costs can reshape returns. That kind of shock often pushes interest toward fast growing Canadian businesses where founders still own a lot of stock and have their own wealth at risk. This article highlights three

GLOBAL MARKET CALL: Downgrading ‘Go Global’ To Market Weight

We are downgrading the “Go Global” portfolio strategy from overweight to market weight and raising “Stay Home” (in the US) from underweight to market weight. Overseas earnings remain impressive, but the rallies in emerging market economies’ stock markets have been led by just a handful of AI-related stocks. Last week’s rout in South Korea showed

Netflix Stock Has Been on a Roll. Here’s Where It Could Go Next.

Quick Read Netflix trades at $72.56 with a BUY rating and $81.87 price target, implying 13% upside despite a 23% year-to-date decline. Disney trades at 14x forward earnings with half Netflix’s revenue growth, making Netflix’s 19x multiple look reasonable by comparison. Netflix’s $4.7B record buyback quarter and $27B remaining capacity anchor the bull case alongside

SpaceX Faces Major Challenges Building Mobile Network After Spectrum Purchase

SpaceX Faces Major Challenges Building Mobile Network After Spectrum Purchase ©@Kmeel_com from pixabay via Canva, @3DSculptor from Getty Images via Canva Key Stats for SpaceX Stock Price change for SpaceX stock in last 1 month: -4% $SPCX Stock Price as of Oct. 16: $146 52-Week High: $226 $SPCX Stock Price Target: $223 What Happened? SpaceX

Kim Jong Un oversees the missile test on TV, accompanied by his daughter, Ju Ae, (AP/PTI)

Inside Kim Jong Un’s world of luxury: mega yachts, armoured trains and designer wear

A spectacular swimming pool stretching across the deck on an 80-metre luxury vessel, complete with waterslides at one end, has emerged as a striking symbol of the privileged lifestyle enjoyed by North Korea’s elite. Kim Jong Un oversees the missile test on TV, accompanied by his daughter, Ju Ae, (AP/PTI) According to the BBC, satellite

Netflix Stock Has Gained in the Fourth Quarter in 17 of the Last 24 Years

Netflix (NASDAQ:NFLX) has a good fourth-quarter record. Going back to 2002, the shares ended the final three months of the year up in 17 of 24 years. This count goes from the last closing price in September to the last close in December, adjusted for stock splits. And in a typical year, the rise was

The problem with telling people the world is ending | Climate crisis

The problem with telling people the world is ending | Climate crisis

These days, it’s easy to succumb to hopelessness. Whether you’re thinking about the climate crisis, the prospect of AI apocalypse, war or political turmoil, the list of challenges facing humanity can seem insurmountable. It certainly feels unprecedented, and much of it may be. The sense of impending doom, on the other hand, is nothing new.

Mohammed Yaseen

Former member of deadly Isis cell spotted at King’s local Co-op

18 Oct 2026, 10:10Updated: 3h ago The former convicted terrorist previously entered the UK with a false name. 18 Oct 2026, 10:10 | Updated: 3h ago Enjoy your favourite LBC shows with ad-free Catch Up, weekly competition entries and an exclusive newsletter. Subscribe to LBC Catch Up Plus from £4.99 a month Mohammed Yaseen. Picture:

Michael Burry Warns of a Stock Market ‘Supervolcano’

Photo by BeInCrypto Michael Burry, who bet against the 2008 housing bubble, says the next bear market may last a long time. The Michael Burry bear market warning rests on a century of inflation-adjusted S&P 500 data. On the surface, stocks look calm. The S&P 500 closed at a record on October 6. Yet Burry

Protesters accuse Colombia govt of erasing history at National Museum

Protesters accuse Colombia govt of erasing history at National Museum

Hundreds of demonstrators gathered outside Colombia’s National Museum on Saturday to protest an order by the country’s new right-wing president to remove works related to feminism, the LGBTQ community, the country’s peace process and other topics. Protesters accuse Colombia govt of erasing history at National Museum Dozens of pieces were taken down from the walls

0
Would love your thoughts, please comment.x
()
x